These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2297724)

  • 1. Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts.
    Ali SA; Warren SD; Richter KY; Badger CC; Eary JF; Press OW; Krohn KA; Bernstein ID; Nelp WB
    Cancer Res; 1990 Feb; 50(3 Suppl):783s-788s. PubMed ID: 2297724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies.
    Ali SA; Eary JF; Warren SD; Badger CC; Krohn KA
    Int J Rad Appl Instrum B; 1988; 15(5):557-61. PubMed ID: 3254878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved iodine radiolabels for monoclonal antibody therapy.
    Stein R; Govindan SV; Mattes MJ; Chen S; Reed L; Newsome G; McBride BJ; Griffiths GL; Hansen HJ; Goldenberg DM
    Cancer Res; 2003 Jan; 63(1):111-8. PubMed ID: 12517786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
    Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
    Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
    Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
    Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
    Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model.
    Badger CC; Wilbur DS; Hadley SW; Fritzberg AR; Bernstein ID
    Int J Rad Appl Instrum B; 1990; 17(4):381-7. PubMed ID: 2387747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
    Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR
    J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specifically radioiodinated antibody for targeting tumors.
    Rea DW; Ultee ME; Belinka BA; Coughlin DJ; Alvarez VL
    Cancer Res; 1990 Feb; 50(3 Suppl):857s-861s. PubMed ID: 2297734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice.
    Karmani L; Levêque P; Bouzin C; Bol A; Dieu M; Walrand S; Vander Borght T; Feron O; Grégoire V; Bonifazi D; Michiels C; Lucas S; Gallez B
    Nucl Med Biol; 2016 Jul; 43(7):415-23. PubMed ID: 27179250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy.
    Kim EJ; Kim BS; Choi DB; Chi SG; Choi TH
    Oncol Rep; 2016 Jun; 35(6):3159-68. PubMed ID: 27035553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
    Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies.
    De Nardo GL; De Nardo SJ; Miyao NP; Mills SL; Peng JS; O'Grady LF; Epstein AL; Young WC
    Int J Biol Markers; 1988; 3(1):1-9. PubMed ID: 3249042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody.
    Turner CJ; Sykes TR; Longenecker BM; Noujaim AA
    Int J Rad Appl Instrum B; 1988; 15(6):701-6. PubMed ID: 3251903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids.
    Govindan SV; Mattes MJ; Stein R; McBride BJ; Karacay H; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1999; 10(2):231-40. PubMed ID: 10077472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ; Archer GE; Wikstrand CJ; Bigner DD; Zalutsky MR
    Cancer Res; 1997 Apr; 57(8):1510-5. PubMed ID: 9108453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The catabolism of radioiodinated anti-lung-cancer monoclonal antibodies in tumor-bearing nude mice].
    Shi X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):422-7. PubMed ID: 1838958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
    Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
    Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.